# ABBVIE INC.: Commercial Filing (, NY) — HONOR THE CONTRACT (MID-YEAR PRESCRIPTION DRUG FORMULARY CHANGES), PHARMACEUTICAL ISSUES; PRESCRIBER PREVAILS, MEDICAID DRUG CAP, OPIOID SURCHARGE, DRUG TAKE BACK, NON-MEDICAL SWITCHING, CLINICAL REVIEW/PRIOR AUTHORIZATION, ENDOMETRIOSIS RESOLUTION, PUBLIC HEA

**Score:** 55/100

| Field | Value |
|---|---|
| Organization | ABBVIE INC. |
| Classification | Commercial Filing |
| Status | HONOR THE CONTRACT (MID-YEAR PRESCRIPTION DRUG FORMULARY CHANGES), PHARMACEUTICAL ISSUES; PRESCRIBER PREVAILS, MEDICAID DRUG CAP, OPIOID SURCHARGE, DRUG TAKE BACK, NON-MEDICAL SWITCHING, CLINICAL REVIEW/PRIOR AUTHORIZATION, ENDOMETRIOSIS RESOLUTION, PUBLIC HEALTH PROPOSALS RELATED TO PATIENT ACCESS AND PROPOSALS RELATED TO THE PHARMACEUTICAL INDUSTRY. |
| Location | NY |
| Reported value | Not stated |
| Reference ID | 2237 |

## Why this score
- Pending review window — early commercial trigger.

Source: New York State Open Data (data.ny.gov, dataset 8bmh-tuz3) (https://data.ny.gov/d/8bmh-tuz3). Last refreshed: 2026-11-03T19:58:33.468Z.
Public record data from New York State Open Data (data.ny.gov, dataset 8bmh-tuz3). Filtered to commercial organizations; individual consumer and residential records are excluded. A public filing or inspection record is not a finding of fault and does not establish legal liability. Verify directly with New York State before acting.